Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Apply
VMD-928
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step